- Contraception For Teens: Let's Talk About It
- Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
- ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win
- ASCO: With bispecifics on its heels, Incyte positions Monjuvi combo for first-line DLBCL
- 6 dental technology updates in May
- From clinician to leader: Building confidence, capability and leadership in dentistry
- Operationalizing AI at scale: A practical framework for enterprise-scale success
- 3 key stats on the orthodontist workforce
- Meet the COOs of 10 specialty DSOs
- Data, cross-training, and pipeline development: How health systems are rethinking OR staffing
- How top health systems are redefining the digital patient experience
- ‘The most significant change in 20 years’: Cancer centers prepare for daraxonrasib demand
- A Smooth Handoff From Decision to Dollars: Connecting the Last Mile in Healthcare Payments
- Budget-Strapped Montana Will Stress-Test Trump’s Medicaid Work Rules
- How CEOs actually use hospital rankings — and when they don’t
- What OU Health’s founding CEO learned building a new health system
- Arkansas hospital CEO to step down after 11 years for new role
- The behavioral health workforce pipeline: Where it stands and where it’s headed
- 6 major investments in youth behavioral health
- Coalition for Health AI unveils governance playbook for systems
- 66 health systems ranked by long-term debt
- UnitedHealthcare drops some prior auth requirements for cardiology, orthopedic services
- 8 No Surprises Act shake-ups physicians need to know
- The ASC independence playbook: 3 leaders’ thoughts
- Dr. Rahimah Maina opens new dental practice
- GWU offloaded its $450M physician group problem — why the industry watching
- The gastroenterologist pay gap
- Texas surgery center to double in size, add 2 ORs
- What dental leaders told us in May
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- What’s going on at the FTC? 3 notes for ASC leaders
- 8 DSOs making headlines
- The physician noncompete battle in 5 key figures
- The physician red flags that can predict a bad ASC partner
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Nearly 70% of US counties lack a GI: 13 concerning workforce stats
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- A new behavioral health profession is born
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Dentists’ pay climbed the most in these 10 states
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Massachusetts AG sues UnitedHealthcare over alleged Medicaid fraud
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Weekly Rundown—Moffitt Cancer Center expands Reimagine Care's virtual oncology model; Tanner Health deploys AI workforce solution
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
- Aetna to launch ‘on demand’ virtual mental health services in 2027
- U of Connecticut dental school reappoints dean for 2nd term
- Michigan dentist charged with Medicaid fraud
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- Acadia in the headlines: 6 things to know
- 26 behavioral health executive moves to know
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Behavioral health hospital operator to pay $32M in Medicare fraud settlement
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- CVS expands partnership with Salesforce for greater call center personalization
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- Listen to the Latest ‘KFF Health News Minute’
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Teladoc Health inks partnership with Walmart to expand virtual care services
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Kaléo speaks up on allergy awareness to amplify patient stories
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- NYC Health + Hospitals adds 2nd behavioral health housing site
- Mindfulness isn’t a perk anymore — it’s a workforce strategy
- With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down
- Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- GoodRx launches subscription program for low-cost generic medications, telehealth services
- George Washington University locks deal to hand off debt-ridden physician practice to UHS
- Humana invests $83M in new Florida pharmacy distribution center
- As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey
- ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary
- An insider’s look at LillyDirect
- GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
- Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims
- FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
- Eli Lilly wins argument over Noom’s GLP-1 dosing claims
- Remarks at the Stanford Rock Center for Corporate Governance
- Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
- Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
- JD Power: Cost pressures worsen member experience with commercial plans
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Listen to the Latest ‘KFF Health News Minute’
- As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Common Food Preservatives Linked to Major Heart Problems
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
Opioid addiction is a leading cause of avoidable death in America, but the war on opioid medications which ensued has created a new class of victims, some of whom commit suicide:
https://www.cato.org/blog/chilling-effect-how-fear-drives-doctors-away-pain-patients
The Chilling Effect: How Fear Drives Doctors Away from Pain Patients
By Jeffrey A. Singer - February 25, 2025When Mark Ibsen, MD, spoke as a panelist in the Cato online event “Pain Refugees: Collateral Damage in the War on Drugs” last December, he had no idea that representatives of the Montana Board of Medical Examiners (BOME) were watching. Three days later, he was shocked to receive a letter from BOME demanding he justify mentioning deceased patients by name (possibly violating the Health Insurance Portability and Accountability Act, or HIPAA)—a charge that would later be dropped but sent a clear message: speaking out has consequences. The letter stated:
While investigating the original Complaint, the Department became aware that you identified six former patients by name in the following online forums, which were available to the public:
1) December 22, 2019, written post responding to a blog article entitled “No Help, no medication. I want out. I’m not strong enough” on the Pharmacist Steve website.
2) October 6, 2020, video post on your Facebook page.
3) December 2, 2024, video post on your Facebook page.
4) December 3, 2024, panel discussion hosted on the Cato Institute’s website and video post of the panel discussion on that website.
… Please provide a written response to these additional allegations by the end of the day on December 16, 2024. Please include in your response whether you had written permission from your former patients or other legally authorized individual to disclose the patient’s protected health information in a public setting. If so, please provide copies with your response. (emphasis added)
In 2015, agents from the Drug Enforcement Administration (DEA) raided the office of Christopher Christensen, a Montana physician who was then 67 years old, and arrested him for inappropriately prescribing opioids to his patients. The DEA charged Dr. Christensen with 400 felony drug offenses and two counts of negligent homicide following the overdoses of two patients who had taken his prescribed medication. A jury convicted Christensen in 2017, and the court sentenced him to 20 years in prison, 10 of which were suspended. The Montana Supreme Court overturned the negligent homicide convictions but still required him to serve time in prison for nine counts of criminal endangerment and 11 counts of criminal distribution of dangerous drugs.
Dr. Christensen’s arrest by cops practicing medicine frightened Dr. Ibsen, a Montana primary care and urgent care physician. Dr. Ibsen wrote me: “Before ceasing writing prescriptions for opiates, reported DEA incursions had me thinking that every opiate prescription I wrote could be my last. I worried if I could trust patients to honor their promise that they would not kill themselves with my prescription, as that would take me down as well.” He ceased prescribing opioids for pain in 2017. “I thought I was going to be given an award for weaning 80% of my patients off opioids.”
He tapered his patients’ doses, gave them notice that he would no longer treat them, referred them to other doctors, and prescribed them a 30-day supply of pain medications to tide them over until they saw the other doctors. Unfortunately, other doctors were oftentimes afraid of taking on new pain patients. Some of Ibsen’s former patients grew desperate, and like many across the country in similar straits, some turned to suicide.
At Cato’s pain refugee event, Dr. Ibsen, holding back tears, stated:
Six of my patients died from 2016 to 2018 after I stopped prescribing opiates when Dr. Chris Christensen was convicted. Three of my patients died by gunshot wounds … two by alcohol complications … and one by a non-opioid overdose: Chris Storseht — Jennifer Adams – Robert Mason – Jennifer Beausoleil – John Burke- Lynette Chadwick.
At the BOME Screening Panel hearing this month, the BOME attorney never mentioned HIPAA violations when summarizing the Board’s concerns. The physician chairing the panel didn’t mention HIPAA violations either.
One of Dr. Ibsen’s chronic pain patients from 2013 provided an affidavit stating:
Information, pictures, and names of chronic pain patients who committed suicide, have been public knowledge for a number of years. … There was a conference put on by the Helena Department of Public Health & Human Services in 2018. A few of us chronic pain patients that belong to an organization called “Don’t Punish Pain” were invited to be on a panel. We talked about, (six) chronic pain patients just in Montana! We held up their pictures as we said each of their names.
But the affidavit wasn’t needed. The panel voted to terminate the investigation.
This might end the Board’s persecution of Dr. Ibsen, but he will always be haunted by the memories of pain patients who suffered so much that they took their own lives.
Ibsen’s story is emblematic of a broader pattern: regulators and law enforcement drive physicians out of pain management, leaving patients nowhere to turn. His decision to stop prescribing opioids after Dr. Christensen’s conviction—out of fear that he could be next—shows the chilling effect of aggressive prosecution. And the tragic outcome for his former patients mirrors what has happened nationwide as pain management has been criminalized.
Jeffery A. Singer has a new book out on April 8th: Your Body, Your Health Care.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















